Lifecore Biomedical Inc
NASDAQ:LFCR

Watchlist Manager
Lifecore Biomedical Inc Logo
Lifecore Biomedical Inc
NASDAQ:LFCR
Watchlist
Price: 7.6 USD 8.11% Market Closed
Market Cap: 279.9m USD
Have any thoughts about
Lifecore Biomedical Inc?
Write Note

Operating Margin
Lifecore Biomedical Inc

-4.7%
Current
-9%
Average
5.6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-4.7%
=
Operating Profit
-6.1m
/
Revenue
128.4m

Operating Margin Across Competitors

Country US
Market Cap 279.9m USD
Operating Margin
-5%
Country JP
Market Cap 53.2T JPY
Operating Margin
8%
Country CH
Market Cap 190.5B CHF
Operating Margin
17%
Country US
Market Cap 80.2B USD
Operating Margin
17%
Country ZA
Market Cap 45.5B Zac
Operating Margin
8%
Country FR
Market Cap 41.2B EUR
Operating Margin
13%
Country MY
Market Cap 167.6B MYR
Operating Margin
6%
Country US
Market Cap 37B USD
Operating Margin
20%
Country ZA
Market Cap 35.9B Zac
Operating Margin
21%
Country CN
Market Cap 258.3B CNY
Operating Margin
25%
Country US
Market Cap 35.2B USD
Operating Margin
19%
No Stocks Found

Lifecore Biomedical Inc
Glance View

Market Cap
279.9m USD
Industry
Food Products

Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Chaska, Minnesota and currently employs 689 full-time employees. The firm offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials, as well as the manufacture of pharmaceutical-grade Hyaluronic Acid. The company provides complete CDMO services for injectable pharmaceuticals and medical devices. The Company’s services include sodium hyaluronate, development, manufacturing, and analytical services. The company offers a range of average molecular weights and custom modifications for research and development (R&D), clinical, and commercial applications. The Company’s therapeutic applications include drug delivery, biomaterials, ophthalmology, orthopedics, aesthetics, oncology, and pain management. Its development capabilities include formulation, sterile filtration, filling, packaging, testing, and secondary sterilization.

LFCR Intrinsic Value
10.95 USD
Undervaluation 31%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-4.7%
=
Operating Profit
-6.1m
/
Revenue
128.4m
What is the Operating Margin of Lifecore Biomedical Inc?

Based on Lifecore Biomedical Inc's most recent financial statements, the company has Operating Margin of -4.7%.